UBS Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.19M | Buy |
1,821,715
+1,418,191
| +351% | +$1.73M | ﹤0.01% | 4890 |
|
|
2025
Q4 | $397K | Buy |
403,524
+88,765
| +28% | +$107K | ﹤0.01% | 6216 |
|
|
2025
Q3 | $397K | Sell |
314,759
-647,913
| -67% | -$699K | ﹤0.01% | 6254 |
|
|
2025
Q2 | $1.08M | Sell |
962,672
-588,409
| -38% | -$684K | ﹤0.01% | 5394 |
|
|
2025
Q1 | $1.23M | Buy |
1,551,081
+447,688
| +41% | +$549K | ﹤0.01% | 5109 |
|
|
2024
Q4 | $1.82M | Buy |
1,103,393
+699,114
| +173% | +$1.76M | ﹤0.01% | 4812 |
|
|
2024
Q3 | $1.41M | Buy |
404,279
+239,923
| +146% | +$934K | ﹤0.01% | 4322 |
|
|
2024
Q2 | $539K | Sell |
164,356
-279,694
| -63% | -$1.22M | ﹤0.01% | 4941 |
|
|
2024
Q1 | $3.26M | Buy |
444,050
+267,745
| +152% | +$1.66M | ﹤0.01% | 3425 |
|
|
2023
Q4 | $659K | Buy |
176,305
+109,595
| +164% | +$259K | ﹤0.01% | 4859 |
|
|
2023
Q3 | $141K | Sell |
66,710
-192,976
| -74% | -$639K | ﹤0.01% | 5614 |
|
|
2023
Q2 | $1.24M | Sell |
259,686
-158,440
| -38% | -$874K | ﹤0.01% | 4033 |
|
|
2023
Q1 | $2.38M | Buy |
418,126
+126,215
| +43% | +$762K | ﹤0.01% | 3238 |
|
|
2022
Q4 | $2.95M | Buy |
291,911
+289,546
| +12,243% | +$5.44M | ﹤0.01% | 2993 |
|
|
2022
Q3 | $53K | Sell |
2,365
-50,123
| -95% | -$1.45M | ﹤0.01% | 6298 |
|
|
2022
Q2 | $1.3M | Sell |
52,488
-87,025
| -62% | -$2.4M | ﹤0.01% | 3500 |
|
|
2022
Q1 | $5.41M | Buy |
139,513
+11,513
| +9% | +$446K | ﹤0.01% | 2462 |
|
|
2021
Q4 | $7.49M | Buy |
128,000
+101,515
| +383% | +$5.75M | ﹤0.01% | 2404 |
|
|
2021
Q3 | $1.57M | Buy |
26,485
+10,877
| +70% | +$853K | ﹤0.01% | 3797 |
|
|
2021
Q2 | $1.35M | Sell |
15,608
-29,388
| -65% | -$2.37M | ﹤0.01% | 3921 |
|
|
2021
Q1 | $3.71M | Sell |
44,996
-42,725
| -49% | -$4.09M | ﹤0.01% | 2933 |
|
|
2020
Q4 | $7.98M | Buy |
87,721
+80,793
| +1,166% | +$5.02M | ﹤0.01% | 2027 |
|
|
2020
Q3 | $277K | Buy |
6,928
+1,717
| +33% | +$60K | ﹤0.01% | 4597 |
|
|
2020
Q2 | $179K | Sell |
5,211
-1,827
| -26% | -$54.5K | ﹤0.01% | 4880 |
|
|
2020
Q1 | $156K | Sell |
7,038
-44,684
| -86% | -$1.13M | ﹤0.01% | 4912 |
|
|
2019
Q4 | $1.01M | Sell |
51,722
-119,783
| -70% | -$1.9M | ﹤0.01% | 4203 |
|
|
2019
Q3 | $2.66M | Buy |
171,505
+133,074
| +346% | +$2.55M | ﹤0.01% | 3017 |
|
|
2019
Q2 | $780K | Buy |
38,431
+28,877
| +302% | +$520K | ﹤0.01% | 3948 |
|
|
2019
Q1 | $168K | Sell |
9,554
-78,398
| -89% | -$1.24M | ﹤0.01% | 4721 |
|
|
2018
Q4 | $1.13M | Buy |
87,952
+57,642
| +190% | +$804K | ﹤0.01% | 3561 |
|
|
2018
Q3 | $494K | Sell |
30,310
-71,100
| -70% | -$841K | ﹤0.01% | 4415 |
|
|
2018
Q2 | $1.15M | Buy |
101,410
+92,252
| +1,007% | +$1.02M | ﹤0.01% | 3660 |
|
|
2018
Q1 | $89K | Buy |
9,158
+3,116
| +52% | +$29.9K | ﹤0.01% | 5292 |
|
|
2017
Q4 | $37K | Buy |
6,042
+4,292
| +245% | +$19.1K | ﹤0.01% | 6077 |
|
|
2017
Q3 | $7K | Sell |
1,750
-41,875
| -96% | -$142K | ﹤0.01% | 7063 |
|
|
2017
Q2 | $141K | Buy |
+43,625
| New | +$167K | ﹤0.01% | 4967 |
|
|
2017
Q1 | – | Sell |
-738
| Closed | -$2K | – | 7733 |
|
|
2016
Q4 | $2K | Sell |
738
-1,537
| -68% | -$4.12K | ﹤0.01% | 7504 |
|
|
2016
Q3 | $7K | Buy |
+2,275
| New | +$5.52K | ﹤0.01% | 6974 |
|
|
2016
Q2 | – | Sell |
-2,127
| Closed | -$4K | – | 7796 |
|
|
2016
Q1 | $4K | Sell |
2,127
-2,103
| -50% | -$4.33K | ﹤0.01% | 7085 |
|
|
2015
Q4 | $14K | Buy |
4,230
+435
| +11% | +$1.83K | ﹤0.01% | 7059 |
|
|
2015
Q3 | $20K | Buy |
+3,795
| New | +$25.9K | ﹤0.01% | 6692 |
|
|
2015
Q2 | – | Sell |
-3,443
| Closed | -$17K | – | 8589 |
|
|
2015
Q1 | $17K | Buy |
3,443
+1,179
| +52% | +$5.84K | ﹤0.01% | 7142 |
|
|
2014
Q4 | $11K | Buy |
+2,264
| New | +$9.99K | ﹤0.01% | 8298 |
|
Other funds holding FATE
RG
VCM
VPM
JJ
